Teladoc (TDOC) Tops Q2 EPS by 7c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Teladoc Health Reports Second Quarter 2025 Results
July 29, 2025 4:05 PM EDTNEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended June 30, 2025 (Second Quarter 2025). Unless otherwise noted, percentage and other changes are relative to the three months ended June 30, 2024 (Second Quarter 2024).
Highlights
Second Quarter 2025 revenue of $631.9 million, down 2% year-over-yearSecond Quarter 2025 net loss of $32.7 million, or $0.19 per shareSecond Quarter 2025 adjusted EBITDA of $69.3 million, down 23% year-over-yearIntegrated Care segment revenue of $391.5 million, up... More